BRPI0919236A2 - terapêutica e vacinas de combinação de gas - Google Patents

terapêutica e vacinas de combinação de gas

Info

Publication number
BRPI0919236A2
BRPI0919236A2 BRPI0919236A BRPI0919236A BRPI0919236A2 BR PI0919236 A2 BRPI0919236 A2 BR PI0919236A2 BR PI0919236 A BRPI0919236 A BR PI0919236A BR PI0919236 A BRPI0919236 A BR PI0919236A BR PI0919236 A2 BRPI0919236 A2 BR PI0919236A2
Authority
BR
Brazil
Prior art keywords
therapy
combination vaccines
gas combination
gas
vaccines
Prior art date
Application number
BRPI0919236A
Other languages
English (en)
Inventor
Andrea Manetti
Giuliano Bensi
Guido Grandi
Imma Margarit Y Ros
Sabrina Capo
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0919236A2 publication Critical patent/BRPI0919236A2/pt
Publication of BRPI0919236A8 publication Critical patent/BRPI0919236A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0919236A 2008-09-17 2009-09-17 Terapêutica e vacinas de combinação de gas BRPI0919236A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9755108P 2008-09-17 2008-09-17
PCT/IB2009/006949 WO2010076618A1 (en) 2008-09-17 2009-09-17 Combination gas vaccines and therapeutics

Publications (2)

Publication Number Publication Date
BRPI0919236A2 true BRPI0919236A2 (pt) 2015-12-15
BRPI0919236A8 BRPI0919236A8 (pt) 2023-01-31

Family

ID=41508998

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919236A BRPI0919236A8 (pt) 2008-09-17 2009-09-17 Terapêutica e vacinas de combinação de gas

Country Status (18)

Country Link
US (2) US20100136041A1 (pt)
EP (1) EP2344523B1 (pt)
JP (2) JP5680536B2 (pt)
CN (1) CN102356090B (pt)
AU (1) AU2009334428B2 (pt)
BR (1) BRPI0919236A8 (pt)
CA (1) CA2737453A1 (pt)
DK (1) DK2344523T3 (pt)
ES (1) ES2566740T3 (pt)
HR (1) HRP20160306T1 (pt)
HU (1) HUE027618T2 (pt)
MX (1) MX2011002760A (pt)
NZ (1) NZ591633A (pt)
PL (1) PL2344523T3 (pt)
SI (1) SI2344523T1 (pt)
SM (1) SMT201600125B (pt)
WO (1) WO2010076618A1 (pt)
ZA (1) ZA201102005B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
PL2493498T3 (pl) 2009-10-30 2017-08-31 Glaxosmithkline Biologicals Sa Oczyszczanie sacharydów otoczkowych staphylococcus aureus typu 5 i typu 8
CN103239734B (zh) * 2012-02-10 2016-02-24 北京艾棣维欣生物技术有限公司 用于预防和/或治疗呼吸道合胞病毒感染的疫苗
GB201206366D0 (en) 2012-04-11 2012-05-23 Absynth Biologics Ltd Bacterial vaccine
AU2013320313B2 (en) * 2012-09-18 2018-07-12 Glaxosmithkline Biologicals Sa Outer membrane vesicles
US10301362B2 (en) 2014-04-15 2019-05-28 Griffith University Group A Streptococcus vaccine
BE1022553A1 (fr) * 2014-05-07 2016-05-31 Glaxosmithkline Biologicals Sa Mutants de spy0269
US10329601B2 (en) * 2015-12-28 2019-06-25 Ionian Technologies, Inc. Nicking and extension amplification reaction (NEAR) of Streptococcus species
CN112442472B (zh) * 2020-11-30 2023-05-26 四川大学华西医院 抗艰难梭菌的重组乳酸乳球菌、活载体疫苗及其制备方法
JPWO2022158373A1 (pt) * 2021-01-19 2022-07-28
GB202215414D0 (en) 2022-10-18 2022-11-30 Glaxosmithkline Biologicals Sa Vaccine
CN116875520B (zh) * 2023-07-12 2024-06-14 吉林农业大学 表达核糖体失活蛋白的乳酸菌及其在抗轮状病毒中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827038D0 (en) * 1988-11-18 1988-12-21 Kehoe M Streptolysin o antigens & uses
US5866135A (en) * 1994-04-21 1999-02-02 North American Vaccine, Inc. Group A streptococcal polysaccharide immunogenic compositions and methods
CA2532369C (en) * 2003-07-31 2016-07-26 Chiron Corporation Immunogenic compositions for streptococcus pyogenes
CA2583803C (en) * 2004-10-08 2014-11-25 Giuliano Bensi Immunogenic and therapeutic compositions for streptococcus pyogenes
EP2094297A2 (en) * 2006-10-30 2009-09-02 Novartis AG Immunogenic and therapeutic compositions for streptococcus pyogenes
US8287885B2 (en) * 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
WO2009081274A2 (en) * 2007-12-21 2009-07-02 Novartis Ag Mutant forms of streptolysin o

Also Published As

Publication number Publication date
SMT201600125B (it) 2016-07-01
EP2344523B1 (en) 2016-02-10
CN102356090A (zh) 2012-02-15
BRPI0919236A8 (pt) 2023-01-31
DK2344523T3 (da) 2016-04-18
AU2009334428B2 (en) 2014-02-20
ZA201102005B (en) 2016-09-28
JP2012502969A (ja) 2012-02-02
NZ591633A (en) 2012-10-26
WO2010076618A1 (en) 2010-07-08
HUE027618T2 (en) 2016-11-28
JP5680536B2 (ja) 2015-03-04
CA2737453A1 (en) 2010-07-08
EP2344523A1 (en) 2011-07-20
ES2566740T3 (es) 2016-04-15
SI2344523T1 (sl) 2016-06-30
HRP20160306T1 (hr) 2016-04-22
US20100136041A1 (en) 2010-06-03
AU2009334428A1 (en) 2010-07-08
JP2015038156A (ja) 2015-02-26
PL2344523T3 (pl) 2016-09-30
US20150132337A1 (en) 2015-05-14
CN102356090B (zh) 2016-01-20
MX2011002760A (es) 2011-06-16

Similar Documents

Publication Publication Date Title
BRPI0919236A2 (pt) terapêutica e vacinas de combinação de gas
SMT201500177B (it) Combinazione terapeutica comprendente dolutegravir, abacavir e lamivudina
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI0909770A2 (pt) Vacina, e, kit
FI20085334A0 (fi) Harjoitusmenetelmä ja -järjestelmä
DE602009000539D1 (de) Strahlentherapiegerät
CR10571A (es) Vacuna virica recombinante
DE102009036860A8 (de) Bedieneinheit, Gerät und Verfahren
ATE450271T1 (de) Impfstoff
BRPI0921426A2 (pt) dispositivo inalador
BR112012003844A2 (pt) vacinas de pttv e diagnóstico
BR112012000032A2 (pt) meios terapêuticos e diagnósticos inovadores
BRPI0920743A2 (pt) ribonucleases terapeuticas
FI20085696A (fi) Liesiturvajärjestelmä
FI20095134A (fi) Menetelmä pitolaitteen käyttämiseksi ja pitolaite
ZA201103645B (en) Single-time vaccines
DK2293846T3 (da) Depsipeptider og deres terapeutiske anvendelse
DK2310383T3 (da) 2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf
FI20096164A0 (fi) Telakäyttö, tela ja menetelmä
HRP20180744T1 (hr) Terapeutska cjepiva
FI20085531A (fi) Ilmankäsittelylaite
DK2310037T3 (da) Conglutin-gamma as-medikament og -kosttilskudpatentkrav
IT1391542B1 (it) Cassaforte
FI20115894L (fi) Pumppausjärjestelmä ja -menetelmä
FI8286U1 (fi) Kunto- ja terapiaväline

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: GLAXOSMITHKLINE BIOLOGICALS S.A. (BE)